COGNIZANT TECHNOLOGY SOLUTIONS CORP·4

May 29, 4:07 PM ET

Patsalos-Fox Michael 4

Research Summary

AI-generated summary

Updated

Cognizant (CTSH) Director Michael Patsalos-Fox Receives Award

What Happened

  • Michael Patsalos-Fox, a director of Cognizant Technology Solutions (CTSH), was granted a total of 54.087 restricted/deferred restricted stock units on 2026-05-27 (36.075 deferred RSUs + 18.012 RSUs). Each unit represents a right to one share of the company's Class A common stock. The awards are recorded at $0.00 per unit on the Form 4 (transaction code A).

Key Details

  • Transaction date(s) and price(s): 2026-05-27; both grants reported at $0.00 per unit (award/derivative).
  • Total units granted: 36.075 deferred RSUs + 18.012 restricted RSUs = 54.087 RSUs.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Footnotes of note:
    • F1: Deferred RSUs reflect dividend equivalent rights on previously outstanding deferred RSUs.
    • F2: Those deferred RSUs are fully vested and will be settled upon the reporting person’s termination of Board service.
    • F3: The RSUs reflect dividend equivalents on previously outstanding RSUs; each RSU is a contingent right to one Class A share.
    • F4: The restricted RSUs will vest fully on June 3, 2026.
  • Filing timeliness: Report filed 2026-05-29 for a 2026-05-27 transaction — appears timely (filed within the typical two-business-day window).

Context

  • These are awards (derivative RSUs), not open-market purchases or sales. Deferred RSUs are vested but payable on termination of service; the other RSUs vest on a future date (June 3, 2026). Such grants are commonly part of director compensation and are different from immediate purchases or sales—economic benefit depends on future settlement and the company’s share price at that time.